Skip to main content

Living Legend Dr. Robert Gallo and His Legacy at the University of Maryland School of Medicine’s Institute of Human Virology

March 30, 2023

Robert C. Gallo

Robert Gallo, MD, is internationally renowned as a co-discoverer of HIV, the cause of AIDS, and as a two-time recipient of the prestigious Albert Lasker Award – a program established in 1945 to honor individuals who have made major contributions to medical science or who have performed public service on behalf of medicine. He received the first Lasker Award for Basic Science in 1982 for his discovery of the first human RNA tumor virus [the old name for retroviruses] and its association with certain leukemias and lymphomas. In 1986, he received the Lasker-DeBakey Clinical Medical Research Award for his co-discovery of the retrovirus now known as HIV-1 as the cause of AIDS.

“The foundation laid by Dr. Gallo and his co-founders, and nearly three decades of progressive scientific achievement since, have ensured IHV’s continued success and position as a global leader in the research of HIV/AIDS and other chronic viral diseases and cancer,” said University of Maryland, Baltimore President Bruce E. Jarrell, MD, FACS.

Bruce E. Jarrell, MD, FACS

Dr. Gallo established the Institute of Human Virology, the first-of-its-kind virology center that combines the disciplines of research, patient care, and prevention in a combined effort to speed the pace of medical breakthroughs and deliver care. Since its inception, the Institute has treated more than 2 million patients worldwide and approximately 5,000 patients each year for a variety of chronic and deadly viruses and immune disorders, most notably HIV. Prior to founding the institute, Dr. Gallo spent 30 years at the National Institutes of Health's National Cancer Institute, where he was head of its Laboratory of Tumor Cell Biology.

Mark T. Gladwin, MD“Robert Gallo is a world-renowned scientist whose breakthrough discoveries and scholarly contributions have made major contributions to foundational science for more than four decades,” said Mark T. Gladwin, MD, the John Z. and Akiko K. Bowers Distinguished Professor and Dean at the University of Maryland School of Medicine and Vice President, Medical Affairs at University of Maryland, Baltimore. “He is a visionary investigator who has unlocked many important mysteries of human viruses and diseases. Few living scientists have contributed so much to fundamental science, from the discovery of transfer RNAs, DNA polymerase, the first human retroviruses, the inflammatory cytokine Interleukin-2, and the molecular basis for viral-induced oncogenesis. He has been one of our most distinguished members of the University of Maryland School of Medicine faculty for many years and holds the unique distinction of twice winning America's most prestigious scientific award — the Albert Lasker Award in Medicine.”

Molecular Biology and Basic Immunology

Dr. Gallo's legendary scientific career spans six decades. His major impact on scientific discovery began in the 1970s when he characterized all 61 types of the transfer RNAs in animal cells, which are used as essential adaptors when genetic messages are converted into proteins. Then, with a coworker, he described in human cells the enzyme that makes copies of DNA, known as DNA polymerase. In 1976, he identified the first cytokine, which is a chemical messenger that activates the immune system. This cytokine, Interleukin-2, first allowed researchers to grow T-cells in the laboratory and later was used to develop cancer immunotherapy.

Robert Gallo, MD, and Mario Stevenson, PhD“Bob Gallo has had an unparalleled impact on our understanding of the inner workings of infectious agents that afflict humans. The breadth and importance of his discoveries are astounding. There have been tremendous advances in the war on HIV/AIDS and without Bob’s contributions, we would not be where we are today,” said Mario Stevenson, PhD, Professor of Medicine, Chief of the Division of Infectious Diseases, Director of the Institute of AIDS at the University of Miami Miller School of Medicine and Chair of IHV’s Scientific Advisory Board and Center of Excellence Director of the GVN. “His vast impact on our scientific understanding cannot be understated.”

Virology

In 1980, Dr. Gallo and colleagues discovered the first retrovirus, Human T-Cell Leukemia Virus-1 (HTLV-1) also the first virus shown to directly cause cancer, not only contribute to it as some other viruses identified before it. Two years later, he identified a second retrovirus HTLV-2. These initial retroviral discoveries paved the way for identifying HIV. In 1986, he discovered the first new human herpes virus in more than 25 years, HHV-6, which causes roseola infantum, a fever and rash in infants, and possibly involved in some dementia.

Robert Gallo, MD, and Peter Palese, PhDIn 1985, Dr. Gallo and his team developed the first HIV blood test, which has been updated by him and other over the years, allowing patient diagnoses and screening of blood used for transfusions. Dr. Gallo and his colleagues were important participants in an NCI-led project with the Burroughs Wellcome Fund developing the antiretroviral drug AZT as the first AIDS therapy.

“Dr. Gallo’s career has been unique and awe-inspiring. He discovered Il-2, a cytokine, which made it possible to grow T-cells. This led to the discovery of the first human RNA virus, HTLV-1, and allowed Dr. Gallo and his colleagues to determine that another retrovirus is the cause of acquired immunodeficiency syndrome (AIDS). Twenty-seven years ago, he founded the Institute of Human Virology in Baltimore. Dr. Gallo’s vision, creativity, and boundless energy made the IHV a world-renowned institution,” said Peter Palese, PhD, Horace W. Goldsmith Professor at the Icahn School of Medicine at Mount Sinai, Center of Excellence Director at the GVN, and member of the U.S. National Academy of Sciences. Dr. Palese is also a member of IHV Scientific Advisory Board and Board of Advisors. He is a recipient of the 2017 IHV Lifetime Achievement Award for Scientific Contributions.

Global Public Health

In the early 2000s, Dr. Gallo and his colleagues at IHV developed an HIV vaccine candidate that has now progressed to a Phase Ib clinical trial in Thailand, a true example of IHV’s bench-to-bedside mission.

Robert Gallo, MD, and The Honorable Kathleen Kennedy Townsend, JD“Bob’s brilliant scientific breakthroughs saved millions of lives. But he was not satisfied. He created a team of extraordinary of scientists, epidemiologist, and doctors to make sure that science would be used in the most efficient and effective way. That team, centered in Baltimore, spread its passion and knowledge worldwide to cities, to small towns, rural communities. Filled with unmatched energy and daring, Bob is one of history’s great explorers, attracting friends and admirers wherever he goes,” said The Honorable Kathleen Kennedy Townsend, former Chair of the Board of Advisors of the IHV, former chair of the Board of Directors of the GVN, recipient of the 2019 IHV Lifetime Achievement Award for Public Service and Secretary Representative for Pensions and Retirement, U.S. Department of Labor. In her previous role as Lt. Governor of Maryland, Kennedy Townsend recruited Gallo and his team to establish the Institute in the State of Maryland in 1996.

In 2011, Dr. Gallo co-founded the GVN, an organization essential and critical in preparedness, defense, and first response to emerging, existing, and unidentified viruses that pose a clear and present threat to public health. The GVN is a coalition of eminent virologists from 71 Centers of Excellence and 9 Affiliates in 40 countries worldwide working in close coordination. The group contributes to the training of the next generation of virologists, advances knowledge about how to identify and diagnose pandemic viruses, manages viral spread, as well as develops drugs, vaccines, and treatments to combat them. 

Terry Lierman and Robert Gallo, MD“Bob Gallo, through his founding and leadership of the Institute of Human Virology in Baltimore has been a God send in many ways,” said Terry Lierman, Co-Chair, IHV Board of Advisors. “He and his colleagues are responsible for the development of more than 500 jobs, and in bringing nearly $2 billion in research revenue to the city and state. Most importantly, literally thousands of lives in Baltimore, the state and the nation have been saved by the Institute’s research, treatment, and prevention programs. Dr Gallo’s energy, tenacity, and vision are an inspiration to anyone who works with him, not to mention the untold benefactors of his deeds. Wow – what a legacy!”

Most recently with the onset of the COVID-19 pandemic, Dr. Gallo along with his GVN colleagues, notably Konstantin Chumakov, PhD, authored two studies that suggested that the oral polio vaccine made from a live, weakened virus may protect people from SARS-CoV-2. These findings suggest that these types of vaccines could be used in a pinch to protect from future pandemics by amping up the body’s first-response innate immune system.

Dr. Gallo received his BA Degree in Biology from Providence College and his MD Degree from Jefferson Medical College. After conducting his Clinical Clerkship at Yale University School of Medicine, he completed his residency at the University of Chicago.

John Evans and Robert Gallo, MD“Bob Gallo’s impact on the scientific world cannot be overstated. He has made so many scientific discoveries including among others, showing HIV as the cause of AIDS. His discoveries have created therapies and therapeutics that have impacted millions of people worldwide. His legacy of curiosity, vision, insight, leadership tenacity, empathy, and humanity serve as a beacon for this and generations to follow,” said John Evans, Co-Chairman of the IHV Board of Advisors and Co-Founder of C-SPAN. He is a recipient of the 2008 IHV Lifetime Achievement Award for Public Service.

Accolades

Through his research legacy, Dr. Gallo has published more than 1,300 scientific papers and a book "Virus Hunting - AIDS, Cancer & the Human Retrovirus: A Story of Scientific Discovery," which has been published in 12 languages. Dr. Gallo was the most cited scientist in the world from 1980-1990 and was ranked third in the world for scientific impact during 1983-2002.

In 1996, Science magazine named his team’s work Breakthrough of the Year for demonstrating that certain cytokines could inactivate the HIV virus. He holds 35 honorary doctorate degrees. A sampling of his most prestigious international awards includes Canada’s Gairdner Foundation International Award; The Japan Prize of Science and Technology; Germany’s Paul Ehrlich and Ludwig Darmstaedter Prize; India’s Birla Prize; France’s Griffuel Prize; Spain’s Prince Asturias Award; Israel’s Dan David Award, the first Otto Herz Cancer Prize, and the Rabbi Shacknai Immunology Prize; Italy’s Premio International Award, International Science Prize, the Magna Graecia International Prize, and Tevere Roma International Award; China’s highest award, the VCANBIO Award for International Cooperation Life Sciences and Medicine; and the World Health Award from former Soviet Union President Gorbachev. 

Dr. Gallo said, “I have for some time been discussing with IHV leadership and campus leadership my transition from Directorship of the Institute to Emeritus Director and Special Advisor to the Dean. In conjunction with Dean Gladwin and President Jarrell, we have initiated a significant and thoughtful recruitment process that will occur over the next year or so. Personally, I could not be prouder of all that this Institute has accomplished since Bill Blattner, Bob Redfield, and I co-founded IHV with the help of our numerous supporters – too many to mention here. I look forward to commemorating the Institute’s achievements during the IHV 25th anniversary meeting September 28-29 at the Four Seasons Hotel in Baltimore, though it has been 27 years, since we officially opened our doors, we had to postpone our plans due to the pandemic. It is a time in my career that I am more than happy to turn over administrative reigns, and hone my attention on science, in particular, on concepts related to origins of some human cancers and on a fuller understanding of how HIV causes disease or pathogenesis, focusing on an attempt to reach a functional cure where patients no longer need therapy. I look forward to continuing my work with the IHV, which will always have a special place in my heart and expanding my work with the Global Virus Network. I appreciate our faculty and staff’s superb commitment to our mission and look forward to working with my colleagues in my new Emeritus and Special Advisor positions. I will forever be grateful to former Governor Parris Glendenning and former Lt. Governor Kathleen Kennedy Townsend, the Maryland legislature and City of Baltimore and City of Baltimore for recruiting us to the State. I especially look forward to this next chapter in my career when I can focus my time more selectively!”

About the Institute of Human Virology

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland, and the University of Maryland Medical System, the IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology, and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders, most notably HIV, the virus that causes AIDS. For more information, visit ihv.org and follow us on Twitter @IHVmaryland.

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world — with 46 academic departments, centers, institutes, and programs, and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished two-time winner of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1.3 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic, and clinically based care for nearly 2 million patients each year. The School of Medicine has nearly $600 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total population of nearly 9,000 faculty and staff, including 2,500 students, trainees, residents, and fellows. The combined School of Medicine and Medical System (“University of Maryland Medicine”) has an annual budget of over $6 billion and an economic impact of nearly $20 billion on the state and local community. The School of Medicine, which ranks as the 8th highest among public medical schools in research productivity (according to the Association of American Medical Colleges profile) is an innovator in translational medicine, with 606 active patents and 52 start-up companies. In the latest U.S. News & World Report ranking of the Best Medical Schools, published in 2021, the UM School of Medicine is ranked #9 among the 92 public medical schools in the U.S., and in the top 15 percent (#27) of all 192 public and private U.S. medical schools. The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu

Contact

Institute of Human Virology
Jennifer Gonzales
Public Relations & Communications Manager
jennifer.gonzales@ihv.umaryland.edu

Related stories

    Thursday, April 27, 2023

    Current HIV Research: Milestones: Dr. Robert C. Gallo and the Discovery of HIV-1

    In this issue of the journal, we inaugurate a new series entitled “Milestones.” This series will encompass interviews with some of the pioneers that have laid the foundations of HIV research. Revisiting these landmarks while taking into account the prospect of their founders should be an inspiration to our readers, particularly the youngest generation. Nobody better than Dr. Robert Gallo could be the protagonist of the inaugural “Milestone,” with his recount of the discovery of HIV-1, the causative agent of AIDS, and the development of the first blood test to diagnose HIV-1 infection.


    Wednesday, March 29, 2023

    Dan Rodricks: What I didn’t know about Dr. Gallo

    Until this week, when I looked deeper into his background for my current Sun column, I did not know Dr. Robert Gallo’s origin story as a scientist. It was the death of his six-year-old sister, Judith, when Gallo was a boy in Connecticut, that launched his career in cancer and virus research. He went on to become one of the leading biomedical researchers in the world, the co-discoverer of HIV and a founder of both the Institute of Human Virology in Baltimore and the Global Virus Network.


    Tuesday, March 28, 2023

    The Baltimore Sun: Dan Rodricks: Renowned scientist Robert Gallo takes on emeritus role at Baltimore’s Institute of Human Virology

    Dr. Robert Gallo, co-discoverer of the human immunodeficiency virus that causes AIDS and one of the world’s most celebrated cancer researchers, has stepped down as director of the Institute of Human Virology that he established in downtown Baltimore 27 years ago. But it’s not like the 86-year-old virologist is retiring.


    Monday, March 06, 2023

    Eradicating Polio Will Require Changing the Current Public Health Strategy

    The recent public health emergency declarations in New York and London due to polio infections and detection of the virus in these cities’ wastewater strongly indicate that polio is no longer close to being eradicated. Now, four members of the Global Virus Network (GVN) proposed changes in global polio eradication strategy to get the world back on track to one day eliminating polio’s threat.


    Tuesday, January 31, 2023

    University of Maryland School of Medicine’s Institute of Human Virology Director Dr. Robert Gallo Co-Authors STAT Op-Ed with a U.S. Government Call to Action and Road Map for the Future of COVID-19

    STAT today published "How the Biden administration’s Covid preparedness policies could narrow America’s political divide" co-authored by leadership of the Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 37 countries, and comprising foremost experts in every class of virus causing disease in humans and some animals. The opinion piece calls on the Biden Administration to “follow the science” in updating COVID-19 preparedness policies to align with the indefinite endemic phase the country is now facing.


    Wednesday, January 18, 2023

    BBC: The scientist who smuggled HIV in her bag into her country to study it and save lives

    Acquired immune deficiency syndrome, AIDS, had been recognized as a new disease in 1981, when an increasing number of young homosexuals died of unusual infections and rare cancers. It was also known to affect intravenous drug users and some were known to have contracted it through blood transfusions.


    Wednesday, January 18, 2023

    Baltimore Banner: Hunt for infectious disease treatments takes on new urgency

    When monkeypox cases began spiking in early June, some of those infected and at risk were dismayed that there weren’t proven therapies ready. There was a promising treatment, tested in animals but not humans, for the infections regularly seen in Africa but rarely reported in Europe or North America. The drug was used sparingly before the emergency began abating. But instead of putting the tecovirimat, or TPOXX, back on the shelf, researchers at Johns Hopkins and elsewhere launched a major study to confirm it worked for monekypox, now known as mpox.


    Friday, January 06, 2023

    USA Today: Fact check: Research proves HIV is the cause of AIDS, contrary to viral claim

    The claim: There is no proof HIV is the cause of AIDS. A Dec. 15 Facebook video shows Kary Mullis, a scientist known for denying the link between HIV and AIDS, claiming again there is no proof HIV is the cause of AIDS. The post was shared more than 1,000 times in a week. The clip comes from a 2009 documentary that promoted AIDS denialism, which has more than 300,000 views on YouTube.


    Tuesday, August 09, 2022

    CNBC: ‘We don’t even agree on how to define it yet’: It’s year three of the pandemic and scientists still know very little about long COVID

    We’ve entered year three of the pandemic, and experts still know very little about long Covid, including how to cure its symptoms. On July 20th and July 21st, the Global Virus Network hosted the first-ever conference devoted solely to the science of long COVID. There, scientists spoke openly about what is known about the mysterious condition and the questions that remain.


    Monday, July 25, 2022

    Institute of Human Virology at the University of Maryland School of Medicine Supports First-of-Its-Kind Conference to Evaluate the Public Health Magnitude of Long COVID And Define A Global Research Roadmap to Address the Crisis

    The conference, hosted at the University of Maryland, Baltimore, reviewed the wealth of cohort data on long COVID, constructed a framework to characterize and define the conditions, and identified the most critical and urgent areas of research needed to better understand, diagnose, and treat this developing public health crisis.


    Friday, July 22, 2022

    STAT: ‘There’s no one long COVID’: Experts struggle to make sense of the continuing mystery

    Presented by the Global Virus Network, a coalition of leading virologists, the two-day virtual conference convened at the University of Maryland, Baltimore where experts across disciplines and around the world to ask and answer questions about what causes long COVID, how to predict who gets it, how to treat it, and just possibly how to prevent it.


    Tuesday, May 24, 2022

    Baltimore Sun: Monkeypox ‘isn’t COVID,’ but CDC still wants public to be aware of cases

    Officials from the U.S. Centers for Disease Control and Prevention warned the public and medical providers Monday to be on alert for possible cases of monkeypox as it counts up to five cases of the normally rare disease around the nation. But the officials say the threat to the general public remains low, as it’s just not as easily spread as other diseases such as COVID-19. Rather, it takes touching or sharing fluids with someone with the characteristic monkeypox rash.


    Thursday, May 19, 2022

    Baltimore Sun: With COVID cases rising, you’re still not fully vaxxed or boosted? Come on now.

    Dan Rodricks: I recently had conversations with a middle-aged man who is extremely careful about what he puts into his body. He eats lots of fruits and vegetables and stays away from red meat and processed foods. He also refuses to get the vaccine against COVID-19, even as infections are on the rise again.


    Tuesday, April 05, 2022

    UM School Of Medicine Institute of Human Virology’s Robert Gallo Receives Distinguished Alumni Award by the University of Chicago Medical Association

    Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the Institute Human Virology at the University of Maryland School of Medicine and Co-Founder and Chair of the Scientific Leadership Board of the Global Virus Network, was awarded the Distinguished Alumni Award by the University of Chicago Medical & Biological Sciences Alumni Association (UChicago MBSAA) for his lifetime achievements. Honorees will participate in a panel discussion on May 10 and will be presented the award on May 21 at the Hyde Parke campus.


    Friday, March 18, 2022

    Deutsche Presse-Agentur: Virus hunt for decades: US researcher Robert Gallo turns 85

    Few scientists in the world can come up with as many successes as Robert Gallo: The US researcher was involved in the discovery of the AIDS virus, found leukemia pathogens and other deadly viruses. Now he is 85 - and works even harder than before.


    Wednesday, February 23, 2022

    TIME: Knowing the Origins of COVID-19 Won't Change Much

    Over two years since the first cases started appearing in Wuhan, China, there is much we don’t know about the origins of SARS-CoV-2, the virus causing COVID-19. But a quick resolution to that question is possible: scientists could find bats in a cave somewhere in China or in southeast Asia and trace a chain leading from those bats to the COVID-19 outbreak in Wuhan. Realistically, however, recent history offers little promise for this to happen quickly.


    Wednesday, February 16, 2022

    WBAL: Maryland HIV researcher on latest research: It's not a cure

    Scientists used a cutting-edge stem cell transplant method to treat a woman's HIV, but a lead researcher in Maryland said it's too soon to celebrate. A U.S. woman is the third known person who is in HIV remission after receiving stem cells from umbilical cord blood, an American research team announced Wednesday.


    Tuesday, February 08, 2022

    The New Yorker: Beyond the Booster Shot

    Could a “broad spectrum” booster increase our immunity to many pathogens simultaneously? The first tuberculosis vaccine was developed in 1921, by two French scientists, Albert Calmette and Camille Guérin. It was called Bacillus Calmette-Guérin, or B.C.G., and has long been one of the world’s most widely administered shots. From the beginning, its power was surprising. B.C.G. contains a bacterium similar to the one that causes TB, and engenders an immune defense specific to that disease. But, as Calmette noted in a paper in 1931, those vaccinated with B.C.G. at birth were around seventy-five per cent less likely to die in their early years of any cause.


    Tuesday, January 04, 2022

    Economy.bg: What do scientists want for 2022?

    Economy.bg asked scientists from Bulgaria and the world what they hope for in 2022.


    Wednesday, December 22, 2021

    Economy.bg: The year through the eyes of scientists

    Economy.bg asked scientists in our country and around the world what they think is the most important of the past 2021


    Thursday, December 16, 2021

    Ren TV (Russia): Virologist who discovered HIV urged to vaccinate children

    Robert Gallo, director and co-founder of the Institute of Human Virology at the University of Maryland and co-founder of the Global Virus Network, discussed why it is important to vaccinate children against coronavirus.


    Tuesday, October 26, 2021

    Correio Braziliense: "It's obvious that no vaccine causes AIDS," says one of the virologists who discovered HIV

    The virologist, and one of the discoverers of HIV, speaks to Correio about statements by President Bolsonaro live on social media


    Friday, July 23, 2021

    WUSA: VERIFY: Here's a look at Japan's vaccination plan

    People online claim the Olympics are in jeopardy because the country has no plan to vaccinate its population. That's false.


    Thursday, July 08, 2021

    Bloomberg News: Dr. Gallo Says COVID-19 Is a Solvable Problem

    Dr. Robert Gallo, The Global Virus Network Co-founder and Director at University of Maryland says COVID-19 is a solvable problem, as obviously it was easy to get a solvable vaccine.


    Saturday, July 03, 2021

    India Today: Exclusive: Virologist Dr. Robert Gallo Speaks On Third Wave, Effects On Children & Other COVID Issues

    Will India and the world see a third wave, if yes then when? How much the third wave will affect children? If mRNA vaccine is the future of COVID-19 vaccines? World's top virologist, Dr. Robert Gallo, answers these and many other questions related to COVID-19 and its vaccination in an exclusive conversation with Rajdeep Sardesai.


    Friday, June 25, 2021

    Doctor Radio: What We Know About the Virology of COVID-19

    Dr. Marc Siegel talks to the Co-founder & Director of the Institute of Human Virology at the University of Maryland School of Medicine and Co-founder for the Global Virus Network, Dr. Robert Gallo, as well as the President of the Global Virus Network, Dr. Christian Brechot, about COVID-19 Origin, Immunity, Vaccines, and Variants.


    Friday, June 25, 2021

    Weather Channel: Mystery Thickens Over COVID-19's Origin; Claims of Hidden Early Genetic Information Attracts Further Scrutiny

    COVID-19 pandemic has been wreaking worldwide havoc for nearly 20 months now. Yet, Its origin and early spread continue to be one of the most intriguing scientific puzzles of recent history. Claims that the earliest coronavirus strains leaked out from a lab in the Wuhan Institute of Virology in China have resurfaced and subsided multiple times, throughout the course of the pandemic. While many such claims were eventually disregarded as unfounded speculations of conspiracy theorists, allegations have continued against the Wuhan lab having known about the infection and its subsequent threat, much before the world at large was aware.


    Tuesday, June 22, 2021

    The Washington Post: Wuhan lab’s classified work complicates search for pandemic’s origins

    The Wuhan lab has drawn global scrutiny because of its research on bat coronaviruses in the city where the pandemic began. The events have shined a light on a research niche that — in China, the United States and elsewhere — operates with heightened secrecy because of the national security risks of handling deadly pathogens.


    Monday, June 21, 2021

    Reuters: India should brace for third COVID-19 wave by Oct, say health experts

    A third wave of coronavirus infections is likely to hit India by October, and although it will be better controlled than the latest outbreak the pandemic will remain a public health threat for at least another year, according to a Reuters poll of medical experts.


    Thursday, June 17, 2021

    Big Biology Podcast: Old vaccines for new pandemics (Episode 66)

    What has COVID-19 taught us about preparing for future epidemics? Can we trigger innate immune responses – our first lines of defense - to mitigate novel infections? Can we use live-attenuated vaccines (LAV) meant for other infections to protect us while we develop specific vaccines for new pathogens? On this episode, we talk to virologists Konstantin Chumakov and Robert Gallo about their recent paper entitled “Old vaccines for new infections”.


    Thursday, June 03, 2021

    Slate: A Very Calm Guide to the Lab Leak Theory

    More than a year into the COVID-19 pandemic, scientists still aren’t sure where exactly the virus that caused this mess came from, and how it was able to spread so rapidly among humans. With the origins of the coronavirus still up in the air, there’s been a lot of talk of the so-called lab leak theory—the idea that the virus spread to people in a laboratory accident, rather than jumping from a wild animal to a human. In recent days, there’s been a flurry of speculation, and it can be hard to parse what the lab leak theory is all about, how likely it is, and why it matters at all. Here’s our attempt to sort some of that out.


    Tuesday, June 01, 2021

    SciDevNet: ‘Old vaccines can fight new pandemics like COVID-19’

    Inoculation with live attenuated vaccines (LAV) such as those used against TB, polio or measles can stimulate the immune system to provide protection against other infectious diseases, including COVID-19, says a new study. People who have been inoculated with one or more LAVs but have no access to the new, specific vaccines against COVID-19 — typically because they are expensive or in short supply — may have some protection during the current pandemic, according to the study.


    Thursday, May 27, 2021

    Baltimore Sun: Maryland researchers study whether HIV cure can come from infusing patients with genetically modified ‘super T cells’

    A week ago, a Washington, D.C., man in his 30s with HIV became the first person to be infused with a heaping load of his own genetically modified cells that a Maryland biotech firm believes one day could lead to the elusive cure for the disease. American Gene Technologies’ method involves taking T cells out of a person’s blood and genetically modifying them in the lab to resist infection before they are reinfused. C. David Pauza is the company’s chief science officer and a former professor and researcher at the University of Maryland School of Medicine’s Institute for Human Virology. Another center evaluating entering the study is Maryland’s Institute for Human Virology, confirmed its co-founder and director, Dr. Robert Gallo, who is internationally regarded for his role in discovering HIV and developing a blood test to detect it.


    Tuesday, May 18, 2021

    Institute of Human Virology Leadership Contributes to Global Virus Network Analysis Suggesting Measles, Polio and Tuberculosis Vaccines May Boost Immunity to Coronavirus

    Institute of Human Virology at the University of Maryland School of Maryland scientists, who are also members of the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence and 11 Affiliates in 35 countries, and colleagues today published a perspective proposing that live attenuated vaccines (LAVs), such as those for tuberculosis, measles, and polio, may induce protective innate immunity that mitigate other infectious diseases, triggering the human body’s natural emergency response to infections including COVID-19 as well as future pandemic threats.


    Monday, April 19, 2021

    Bloomberg TV: Will Vaccines Protect Us From All Covid-19 Variants?

    Dr. Robert Gallo, co-founder of the Global Virus Network and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the global rollout of Covid-19 vaccines. Global cases passed 141 million, and deaths exceeded 3 million. Gallo speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Australia."


    Monday, April 19, 2021

    China Business Network: An interview with Dr. Gallo on COVID-19, Variants and Vaccines

    In an exclusive interview with CBN, Dr. Robert Gallo, a world-renowned virus expert, speculated that certain components of Johnson & Johnson and AstraZeneca vaccines may induce the immune system to produce an antibody, which can cause a very small number of people. Heparin-induced thrombocytopenia, thrombosis.


    Friday, April 09, 2021

    Aljazeera: Which vaccine is best? The one you can get first, experts say

    As the United States ramps up its COVID-19 inoculation campaign, aiming to make vaccines available to all adults by April 19, some doctors and health workers are concerned that brand preferences among potential vaccine recipients could hurt attempts to slow the spread of the virus.


    Thursday, April 01, 2021

    Associated Press: Can I still spread the coronavirus after I’m vaccinated?

    Can I still spread the coronavirus after I’m vaccinated? It’s possible. Experts say the risk is low, but are still studying how well the shots blunt the spread of the virus. The current vaccines are highly effective at preventing people from getting seriously sick with COVID-19.


    Monday, December 21, 2020

    Robert Gallo of the UM School of Medicine Institute of Human Virology and Global Virus Network Awarded Top Life Sciences and Medicine Prize from China

    Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded the “VCANBIO Award for Biosciences and Medicine,” a significant and authoritative award in the life sciences and medicine field of China. The elite Prize is jointly presented by the University of Chinese Academy of Sciences and the VCANBIO CELL & GENE ENGINEERING CORP, LTD to push forward scientific research, technological innovation and continuous development in the life sciences and medicine field of China.


    Friday, December 18, 2020

    UMSOM Institute of Human Virology's Robert Gallo Awarded Italy's Magna Graecia International Prize

    Robert Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, was awarded Italy’s “Magna Graecia International Prize,” an award created in 1997 by the Magna Graecia Foundation that is bestowed to the most influential Italians and Italians of origin who have embodied and symbolized, in the most diverse sectors, the best qualities of Italy by extending Italian culture beyond national borders.


    Thursday, October 08, 2020

    NPR: Could The Live Flu Vaccine Help You Fight Off COVID-19?

    In case you were still procrastinating getting a flu shot this year, here's another reason to make it a priority. There's a chance the vaccine could offer some protection against COVID-19 itself, says virologist Robert Gallo, who directs the Institute of Human Virology at the University of Maryland School of Medicine and is chairman of the Global Virus Network.


    Thursday, September 24, 2020

    Baltimore Sun: A vaccine will help, not end coronavirus pandemic, experts in Maryland and globally say

    A global group of virus experts warned Thursday about relying too much on the first vaccines to end the coronavirus pandemic. “If we get a perfect vaccine, great, but that’s unlikely,” said Dr. Robert Gallo, co-founder of the Global Virus Network, during a news conference following a meeting of the organization that works to understand and treat infectious diseases.


    Friday, August 21, 2020

    Institute of Human Virology and Italian Researchers identify a SARS-CoV-2 Viral Strain with Deletion in a Protein, Possibly Reducing Fatalities

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine, a Global Virus Network (GVN) Center of Excellence, in collaboration with scientists from Campus Biomedico in Rome, Italy announced today the results of studies showing the emergence of a SARS-CoV-2 viral strain with a deletion in a protein known as nsp1. These data, accepted for publication today by the Journal of Translational Medicine, (link here) may indicate the emergence of a less pathogenic viral strain.


    Tuesday, June 30, 2020

    Wall Street Journal Op-Ed: An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.

    In this op-ed coauthored by Dr. Robert C. Gallo and Daniel J. Arbess, they discuss how “An Old Vaccine May Help Against Coronavirus: A tablet for polio boosts innate immunity, which fights other viruses.”


    Monday, June 29, 2020

    Baltimore Magazine Special Edition: Dr. Gallo Featured

    Dr. Robert Gallo is featured in Baltimore Magazine's special edition, "On the Front Lines: Acts of Courage and Kindness in the Age of Coronavirus."


    Thursday, June 11, 2020

    Global Virus Network Suggests Oral Polio Vaccine May Provide Temporary Protection Against COVID-19

    The Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 53 Centers of Excellence, including the Institute of Human Virology at the University of Maryland School of Medicine, and 10 Affiliates in 32 countries, published a viewpoint in Science today that the stimulation of innate immunity by live attenuated vaccines in general, and oral poliovirus vaccine (OPV) in particular, could provide temporary protection against coronavirus disease 2019 (COVID-19).


    Friday, May 01, 2020

    NYT Op-Ed Features Gallo-Chumakov Oral Polio Vaccine for COVID-19 Idea

    What if We Already Have a Coronavirus Vaccine? Researchers are testing whether decades-old vaccines for polio and tuberculosis could protect against infection.


    Wednesday, April 29, 2020

    Dr. Robert Gallo Appears on C-SPAN’s Washington Journal

    Please check out Dr. Robert Gallo’s C-SPAN Washington Journal appearance today to discuss COVID-19 treatments, vaccines, the need for the Global Virus Network, and more.


    Monday, April 27, 2020

    Expert Breaks Down Coronavirus Research: Is it Worse than HIV? Is it Mutating?

    IHV Co-Founder and Director, Robert Gallo, MD is interviewed on LBC, a radio station in the United Kingdom. Darren Adam had Professor Gallo on the line to discuss his research in the past and the work he's carrying out during the coronavirus crisis. "We have learned to live with HIV" Darren began, listing out how it has changed from a death sentence to a disease that humans can live a long life with. He wondered if this could be possibly the path we're taking with Covid-19.


    Wednesday, April 22, 2020

    Dr. Robert Gallo on India Today Discussing the Oral Polio Vaccine for COVID-19

    IndiaToday on Twitter - “Can oral polio vaccine help in fighting #Covid19? @DrRobertCGallo responds. #NewsToday with @sardesairajdeep


    Friday, April 17, 2020

    Dr. Robert Gallo Discusses Repurposing the Oral Polio Vaccine on CNN

    Dr. Robert Gallo discusses repurposing the oral polio vaccine, drug therapies and more on COVID-19 on CNN’s The Lead with Jake Tapper, April 17, 2020.


    Monday, April 13, 2020

    Can an Oral Polio Vaccine Stop COVID-19?

    Please see this just released Associated Press article, “Could old vaccines for other germs protect against COVID-19?” with Dr. Robert Gallo (Institute of Human Virology at the University of Maryland School of Medicine) and Dr. Konstantin Chumakov (U.S. Food and Drug Administration), both of the Global Virus Network (GVN).


    Wednesday, April 08, 2020

    Institute of Human Virology Co-founder on Coronavirus Recovery, Antibody Testing, Drug Testing, Bloomberg TV

    Dr. Robert Gallo, the Institute of Human Virology at the University of Maryland School of Medicine, Co-founder and director discusses the coronavirus. He speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Asia." (Source: Bloomberg)


    Tuesday, April 07, 2020

    A Deep Look Into The Coronavirus with Dr. Robert Gallo on WYPR (Baltimore’s local NPR station)

    (WNPR) Dr. Robert Gallo has been getting to know viruses-- their targets and their weaknesses--for decades, even before he co-discovered the virus that causes AIDS in the 1980s. At the University of Maryland’s Institute for Human Virology, which he heads, Gallo is looking at the coronavirus; he joins us to share his thoughts. Gallo is also co-founder and international scientific advisor at the Global Virus Network.


    Wednesday, April 01, 2020

    Dr. Robert Gallo Featured on MSNBC’s 11th Hour with Brian Williams

    Robert Gallo, MD, Co-Founder and Director of the Institute of Human Virology, discusses SARS-CoV-2/COVID-19, specifically, how he thinks the fight against the Coronavirus is going thus far.


    Friday, October 04, 2019

    Institute of Human Virology Hosts 21st Annual International Meeting of Top Scientists on Ending the HIV/AIDS Epidemic in America and the Intersection of Opioid Use Disorder

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine commenced IHV2019 held Thursday, October 3 through Friday, October 4 at the Four Seasons Hotel in Baltimore, Maryland. This year “Progress in HIV/AIDS: Challenges in 2020” opened with highlights about the recent plan for "Ending the HIV Epidemic by 2030” with expert opinions by ADM Brett Giroir, MD, Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS)


    Monday, August 26, 2019

    Dr. Robert Gallo Featured in Malcolm Gladwell's Podcast, "Revisionist History: The Obscure Virus Club"

    "Revisionist History" by Malcolm Gladwell: “The Obscure Virus Club,” featuring three prominent virologists, including Dr. Robert Gallo (as well as Dr. Ludwig Gross and Dr. Howard Temin).